JPRN-jRCT2031210703已完成1 期
A Multiple-Dose Clinical Study to Evaluate the Safety, Tolerability and Pharmacokinetics of MK-6024 in Healthy Japanese Participants
Yoshiyuki Tanaka0 个研究点目标入组 20 人开始时间: 2022年3月26日最近更新:
适应症
试验速览
- 阶段
- 1 期
- 状态
- 已完成
- 发起方
- 入组人数
- 20
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- >= 20age old 至 <= 65age old（—）
- 性别
- Male
入选标准
- •Healthy male aged 20 to 65 years old with BMI 23 to 40 kg/m2
排除标准
- •Has a history of clinically significant abnormalities or diseases
研究者
相似试验
尚未招募
不适用
A Single and Multiple Dose Study to Assess the Safety, Tolerability and Pharmacokinetics SCH 900931 in Healthy Adult Japanese Subjects.Healthy volunteersOther - Research that is not of generic health relevance and not applicable to specific health categories listed aboveACTRN12611000568910Schering-Plough Research Institute, a Division of Schering Corporation, a Subsidiary of Merck & Co., Inc24
招募中
不适用
Evaluation of the Safety & Effectiveness of the PROMUS Element Everolimus-Eluting Coronary Stent System in patients with new or untreated atherosclerotic coronary artery lesionsACTRN12609000724279Boston Scientific Pty Ltd102
已完成
1 期
A single centre, double blind, randomised, parallel group, ascending single and multiple dose, safety and tolerability, pharmacokinetic and pharmacodynamic study of vaginal ointment in healthy women volunteersInfection - Sexually transmitted infectionsCervical neoplasiaCondyloma acuminatumACTRN12618000883213Zenith Technology Corp Ltd18
招募中
1 期
A Single- and Multiple-Dose Study to Assess the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Single and Multiple Intravenous Doses of LY3002813Alzheimer DiseaseJPRN-jRCT2080223143Eli Lilly Japan K.K.
已完成
不适用
Prospective, multicenter study to evaluate the Safety and performance of a syntHetic tissue sealant in reducing fluid lEakage following elective hepatobiLiary anD pancreatic SurgeryFluid leakage following elective hepatobiliary and pancreatic surgery / leakage of bile and pancreatic juices after surgery10019818NL-OMON55236Polyganics BV, Groningen12